Market Insights Health Medical Technology Medical Devices

General & Plastic Surgery Devices - New Zealand

New Zealand

In New Zealand, the General & Plastic Surgery Devices market market is forecasted to achieve a revenue of NZD US$63.56m by the year 2024.
It is anticipated that the revenue will experience a compound annual growth rate (CAGR 2024-2029) of 6.53%, leading to a market volume of NZD US$87.21m by 2029.
When compared globally, the United States is expected to generate the highest revenue in the market, with an estimated amount of US$9,844.00m in 2024.
The demand for General & Plastic Surgery Devices in New Zealand is increasing due to the country's growing aging population and their desire for cosmetic enhancements.

Key regions: Europe, Japan, United Kingdom, Netherlands, China

Market

Region

Region comparison

Currency

Analyst Opinion

The General & Plastic Surgery Devices market in New Zealand is experiencing steady growth due to increasing customer preferences for cosmetic procedures, advancements in technology, and a growing elderly population. Customer preferences in New Zealand are shifting towards cosmetic procedures, driven by a desire for self-improvement and increased social acceptance of these procedures. This trend is similar to the global market, where there is a growing demand for aesthetic enhancements. In addition, the availability of a wide range of surgical and non-surgical procedures, such as breast augmentation, liposuction, and Botox injections, is attracting customers who are looking to enhance their appearance. The market is also benefiting from advancements in technology, which have made surgical procedures safer and more effective. New Zealand has access to state-of-the-art medical devices and equipment, allowing surgeons to perform procedures with greater precision and minimal invasiveness. These technological advancements have increased the overall satisfaction rate among patients and have contributed to the market growth. The aging population in New Zealand is another factor driving the growth of the General & Plastic Surgery Devices market. As the population ages, there is an increased demand for procedures such as facelifts, eyelid surgeries, and dermal fillers to combat the signs of aging. This trend is expected to continue in the coming years, as the elderly population continues to grow. Local special circumstances in New Zealand, such as the country's geographical location, can impact the market. New Zealand is a relatively small market compared to larger countries, which may limit the availability of certain devices and technologies. However, the country has a well-developed healthcare system and a high level of medical expertise, which attracts patients from both within New Zealand and from overseas. Underlying macroeconomic factors, such as GDP growth and disposable income levels, also play a role in the development of the General & Plastic Surgery Devices market in New Zealand. As the economy grows and disposable income levels increase, more individuals are able to afford cosmetic procedures. Additionally, medical tourism is becoming more prevalent, with patients from other countries seeking affordable and high-quality healthcare services in New Zealand. In conclusion, the General & Plastic Surgery Devices market in New Zealand is experiencing growth due to increasing customer preferences for cosmetic procedures, advancements in technology, a growing elderly population, and underlying macroeconomic factors. The market is expected to continue to expand in the coming years, driven by these factors and the ongoing demand for aesthetic enhancements.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.